Therapeutic Potential of Phytoconstituents in the Management of Hypertension

Tanya Gupta1, Rishabh Chalotra1, Randhir Singh1

  • 1Central University of Punjab Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology Bathinda India.

Insights

Hypertension management is suboptimal with current drugs. Herbal therapies, rich in phytoconstituents like flavonoids, offer a holistic approach with diverse mechanisms to control blood pressure and reduce side effects.

Area of Science:

  • Cardiovascular Pharmacology
  • Natural Product Chemistry
  • Integrative Medicine

Background:

  • Hypertension is a major global health issue and a primary risk factor for cardiovascular diseases (CVDs).
  • Current pharmacological treatments for hypertension often face challenges with suboptimal control, side effects, and patient adherence.
  • This necessitates exploring alternative and complementary therapeutic strategies.

Purpose of the Study:

  • To review the potential of herbal therapies and their phytoconstituents in managing hypertension.
  • To explore the diverse mechanisms of action of plant-derived compounds against hypertension.
  • To assess the role of these natural compounds as adjuvant therapies in hypertension management.

Main Methods:

  • Literature review of preclinical and clinical studies on medicinal plants and their bioactive compounds for hypertension.
  • Analysis of the pharmacological actions of phytoconstituents such as flavonoids, alkaloids, phenolic acids, and terpenes.
  • Evaluation of evidence for synergistic effects with conventional antihypertensive drugs.

Main Results:

  • Medicinal plants contain numerous bioactive phytoconstituents with antihypertensive properties, including ACE inhibition, calcium channel blockade, vasodilation, and antioxidant activity.
  • Flavonoids, alkaloids, phenolic acids, and terpenes exhibit specific mechanisms like enhancing nitric oxide bioavailability, modulating calcium channels, and inhibiting the renin-angiotensin-aldosterone system (RAAS).
  • These phytoconstituents show promise as adjuvant therapies, potentially reducing synthetic drug dosage and minimizing adverse effects.

Conclusions:

  • Herbal therapies offer a promising, holistic approach to hypertension management due to the diverse mechanisms of their phytoconstituents.
  • Plant-derived compounds can act synergistically with conventional treatments, improving efficacy and tolerability.
  • Further research into these natural compounds could lead to improved patient outcomes and adherence in hypertension care.

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
656
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
845
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K